B2V1L8 AF NFT

3-methyl-2-oxobutanoate hydroxymethyltransferase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeid4lodxqvbcmllqjemfnqozqsozqnnfeucbm5yeyzwi4orpob47ue/metadata.json
IPFS of structure file: 
bafybeibmkoq623rnbx4bln7phrowpgj3j6ealdilgbn3lxuqkqwp34znni/AF-B2V1L8-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x71112d4fF7ebb3b617963c05f052289e073082FD
First NFT owner address (bech32): 
genesis1wygj6nlhawemv9uk8szlq53gncrnpqha56an79
Current NFT ID #286623 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
286623
Accession (UniProt):
B2V1L8
Name::
3-methyl-2-oxobutanoate hydroxymethyltransferase
Experimental Method:
Predicted structure
Sequence source:
CLOSTRIDIUM BOTULINUM (STRAIN ALASKA E43 / TYPE E3)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B2V1L8 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B2V1L8|PANB_CLOBA 3-methyl-2-oxobutanoate hydroxymethyltransferase OS=Clostridium botulinum (strain Alaska E43 / Type E3) OX=508767 GN=panB PE=3 SV=1 MKNTIATFQEFKNKGKKISMLTAYDYSMAKIIDESGINGILIGDSLGMVIKGEEDTLSVTVDEIIYHTKSVKKGAKNALIVSDMPFLSYHTSVEEAVKNAGKMIKEGGANAVKLEGGASVIKQIKAIVDAQIPVMGHLGLTPQSVNAFGGFKIQGKSEEAAKRLIEDAKLIEDAGAFAIVLECVPKKVAEIITKEISIPTIGIGAGNECDGQILVYQDMLGMFDDFIPKFVKQYANLGAQMREAIQIYIGEVGEGSFPQDKHSFKIDEKELQKLY